November 28, 2016
Stories this photo appears in:
HEALTHCARE: Zovighian leads new valve division
Edwards Lifesciences Corp. Chief Executive Michael Mussallem reminded the crowd attending the company’s annual investor conference in New York this month that despite the success the company’s had with transcatheter heart valves, the technology is still relatively new.
Irvine-based Edwards Lifesciences Corp. reported $186 million in profit on sales of $842 million—up 47% and 11% respectively—for the quarter ended June 30.
Edwards Lifesciences Corp. in Irvine will buy Valtech Cardio Ltd in Or Yehuda, Israel, for $340 million in cash and stock in a deal expected to close early next year.